ALCL are CD30-positive aggressive lymphoproliferative disorders affecting lymph nodes and extranodal sites and characterized by the expression of the Anaplastic lymphoma kinase (ALK) protein as either ALK-positive and ALK-negative subtypes5. This evidence concerns the gene ALK and lymphoproliferative syndrome.